DB15159InvestigationalProtein Based Therapies
Trevogrumab is under investigation in clinical trial NCT02943239 (Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and Healthy Adult Men).
- Mechanism
- Curator reviewed
Pharmacologically active on Growth/differentiation factor 8
- Code names
- REGN1033
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Trevogrumab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account